Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer

AZD9291 tablets: Part A 80mg od, days 1 and 10 only. Part B 80mg od for 12 months.

Blood samples taken pre and post dosing of AZD9291 following either a period of fasting or consumption of a meal.

Fasted from 10 hours prior to dosing with 80mg AZD9291 tablet and 4 hours after dosing

Allocated breakfast prior to dosing with 80mg AZD9291 tablet

Blood samples taken pre and post dosing of AZD9291 following either a period of fasting or consumption of a meal.